VeriMomdecursinol est-il sûr pendant la grossesse ?
No harmonised CLP classification, SCCS/CIR opinions or regulatory reproductive hazard listings were identified for decursinol; however peer‑reviewed studies show biological activity relevant to implantation/angiogenesis (in vitro increases in endometrial adhesion molecule expression and in vivo/in vitro inhibition of VEGF‑driven angiogenesis), which constitutes demonstrated mechanistic effects that could plausibly influence pregnancy. There are no animal or human reproductive‑toxicity data showing teratogenicity or pregnancy harm for decursinol. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32024510/))
Related ingredients
Frequently asked questions
- decursinol est-il sûr pendant la grossesse ?
- No harmonised CLP classification, SCCS/CIR opinions or regulatory reproductive hazard listings were identified for decursinol; however peer‑reviewed studies show biological activity relevant to implantation/angiogenesis (in vitro increases in endometrial adhesion molecule expression and in vivo/in vitro inhibition of VEGF‑driven angiogenesis), which constitutes demonstrated mechanistic effects that could plausibly influence pregnancy. There are no animal or human reproductive‑toxicity data showing teratogenicity or pregnancy harm for decursinol. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32024510/))
- decursinol est-il sûr pendant l'allaitement ?
- No data were found showing transfer into milk, human lactation exposure, or reproductive classification for decursinol. No regulatory (CIR/SCCS/harmonised CLP) guidance or clinical reports were identified to indicate a breastfeeding hazard. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32024510/))
- decursinol est-il sûr pour la peau de bébé ?
- No infant‑specific safety or dermal‑absorption studies were located. Adult topical cosmetic exposure literature/regulatory sources are absent; because decursinol is a small lipophilic coumarin derivative with measurable bioactivity and dermal use in research contexts, neonatal/infant skin exposure is conservatively assigned higher exposure (+1) due to immature barrier and higher surface‑area:weight; no evidence was found to increase hazard or mechanism scores for infants. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/19228635/?utm_source=openai))
- Comment VeriMom évalue-t-il decursinol ?
- VeriMom évalue decursinol à 87/100 (risque faible) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à decursinol pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à decursinol basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.